288 related articles for article (PubMed ID: 26390100)
21. A Novel Mutation in the type Iα Regulatory Subunit of Protein Kinase A (PRKAR1A) in a Cushing's Syndrome Patient with Primary Pigmented Nodular Adrenocortical Disease.
Mineo R; Tamba S; Yamada Y; Okita T; Kawachi Y; Mori R; Kyo M; Saisho K; Kuroda Y; Yamamoto K; Furuya A; Mukai T; Maekawa T; Nakamura Y; Sasano H; Matsuzawa Y
Intern Med; 2016; 55(17):2433-8. PubMed ID: 27580546
[TBL] [Abstract][Full Text] [Related]
22. Carney complex due to a novel pathogenic variant in the PRKAR1A gene - a case report.
Ferreira SH; Costa MM; Rios E; Santos Silva R; Costa C; Castro-Correia C; Fontoura M
J Pediatr Endocrinol Metab; 2019 Feb; 32(2):197-202. PubMed ID: 30699069
[TBL] [Abstract][Full Text] [Related]
23. Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation.
Storr HL; Metherell LA; Dias R; Savage MO; Rasmussen AK; Clark AJ; Main KM
Horm Res Paediatr; 2010; 73(2):115-9. PubMed ID: 20190548
[TBL] [Abstract][Full Text] [Related]
24. Clinical and endocrinological features of adrenocorticotropic hormone- independent bilateral macronodular adrenocortical hyperplasia.
Shinojima H; Kakizaki H; Usuki T; Harabayashi T; Ameda K; Koyanagi T
J Urol; 2001 Nov; 166(5):1639-42. PubMed ID: 11586192
[TBL] [Abstract][Full Text] [Related]
25. Primary pigmented nodular adrenocortical disease and Cushing's syndrome.
Horvath A; Stratakis C
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1238-44. PubMed ID: 18209861
[TBL] [Abstract][Full Text] [Related]
26. Primary pigmented nodular adrenocortical disease: the original 4 cases revisited after 30 years for follow-up, new investigations, and molecular genetic findings.
Carney JA; Libé R; Bertherat J; Young WF
Am J Surg Pathol; 2014 Sep; 38(9):1266-73. PubMed ID: 24805858
[TBL] [Abstract][Full Text] [Related]
27. [A girl with Cushing's syndrome due to primary pigmented nodular adrenocortical disease].
Bocca G; van Mil EG; Voorhoeve PG; Wijnaendts LC; Delemarre-van de Waal HA
Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2390-3. PubMed ID: 17100132
[TBL] [Abstract][Full Text] [Related]
28. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
29. Role of preoperative iodocholesterol scintiscanning in patients undergoing adrenalectomy for Cushing's syndrome.
Yu KC; Alexander HR; Ziessman HA; Norton JA; Doppman JL; Buell JF; Nieman LK; Cutler GB; Chrousos GP; Fraker DL
Surgery; 1995 Dec; 118(6):981-6; discussion 986-7. PubMed ID: 7491543
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing's syndrome.
Lumachi F; Zucchetta P; Marzola MC; Bui F; Casarrubea G; Angelini F; Favia G
Nucl Med Commun; 2002 May; 23(5):469-73. PubMed ID: 11973488
[TBL] [Abstract][Full Text] [Related]
31. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging.
Doppman JL; Travis WD; Nieman L; Miller DL; Chrousos GP; Gomez MT; Cutler GB; Loriaux DL; Norton JA
Radiology; 1989 Aug; 172(2):415-20. PubMed ID: 2748822
[TBL] [Abstract][Full Text] [Related]
32. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[TBL] [Abstract][Full Text] [Related]
33. An unusual cause of Cushing's syndrome: primary pigmented nodular adrenal dysplasia.
Sofat N; Turner J; Khoo B; Sohail M; Krausz T; Evans P; Meeran K
Int J Clin Pract; 2000 May; 54(4):269-71. PubMed ID: 10912321
[TBL] [Abstract][Full Text] [Related]
34. Unravelling the mystery in a case of persistent ACTH-independent Cushing's syndrome.
Lim LC; Tan LH; Rajasoorya C
Ann Acad Med Singap; 2006 Dec; 35(12):892-6. PubMed ID: 17219002
[TBL] [Abstract][Full Text] [Related]
35. Cushing's syndrome due to primary pigmented nodular adrenal disease in two brothers with Carney complex.
Attri B; Aggarwal A; Mattoo S; Kulshreshtha B
Pediatr Endocrinol Diabetes Metab; 2020; 26(3):155-158. PubMed ID: 32901471
[TBL] [Abstract][Full Text] [Related]
36. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
37. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.
Groussin L; Horvath A; Jullian E; Boikos S; Rene-Corail F; Lefebvre H; Cephise-Velayoudom FL; Vantyghem MC; Chanson P; Conte-Devolx B; Lucas M; Gentil A; Malchoff CD; Tissier F; Carney JA; Bertagna X; Stratakis CA; Bertherat J
J Clin Endocrinol Metab; 2006 May; 91(5):1943-9. PubMed ID: 16464939
[TBL] [Abstract][Full Text] [Related]
38. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
[TBL] [Abstract][Full Text] [Related]
39. The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
Gross MD; Valk TW; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Clin Endocrinol Metab; 1981 Jun; 52(6):1062-6. PubMed ID: 6262361
[TBL] [Abstract][Full Text] [Related]
40. Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
Yu KC; Fraker DL; Ziessman HA
Clin Nucl Med; 1996 Feb; 21(2):136-41. PubMed ID: 8697685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
